3-hydroxyflavone has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, XF; Chen, Y; Liu, LL; Luo, HQ; Meng, GL; Sun, LL; Wang, HX; Wang, YQ; Xu, MT; Yu, J; Zhang, JY | 1 |
| Dai, G; Dong, B; Dong, Y; Fan, W; Huang, H; Jiang, J; Liang, Z; Liu, C; Su, Q; Sun, Y; Wang, Y; Xue, R; Zhao, J | 1 |
2 other study(ies) available for 3-hydroxyflavone and Cardiac Hypertrophy
| Article | Year |
|---|---|
Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement.
Topics: Animals; Antioxidants; Cardiomegaly; Flavonols; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Signal Transduction; Sirtuin 3; Ventricular Outflow Obstruction | 2018 |
Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress.
Topics: Acetylcysteine; Animals; Cardiomegaly; Drug Synergism; Enzymes; Flavonoids; Flavonols; Gene Expression Regulation; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; TOR Serine-Threonine Kinases | 2018 |